| Pharmaceutical active ingredients: |
| Cilazapril |
| Available forms, composition and doses of Vascace: |
| Tablets, Film-Coated; Oral; Cilazapril 1 mgTablets, Film-Coated; Oral; Cilazapril 2.5 mgTablets; Oral; Cilazapril 0.5 mgTablets; Oral; Cilazapril 1 mgTablets; Oral; Cilazapril 2.5 mgTablets; Oral; Cilazapril 5 mg |
| Vascace medical category: |
| Human:Angiotensin-Converting Enzyme inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C09AA08 - Cilazapril |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| RocheZuellig Pharma |
| Related documents and information about Vascace: |
| Vascace prescribing information (PDF) |